Systematic evaluation (qRT-PCR and Western blotting) further identified substantial downregulation of AHSP (α-hemoglobin stabilizing protein), accompanied by increased MYB (Myeloblastosis oncogene) expression in AML specimens. This evidence concerns the gene MYB and acute myeloid leukemia.